close menu
X

Anfarm Hellas S.A. - Main Section

Anfarm Hellas S.A. - Main Component

Active Substance Strength Form
TeicoplaninUnder Development 200 mg & 400 mg/vial Pd.Sol.Inf
Tenoxicam 20mg/Vial Ps.Inj.Sol
Tenoxicam 20mg F.C.Tab
Terbinafine HCl 1% w/w (Tubx15g) Cr.Ext.Us
Ticlopidine HCl 250mg Caps
Tigecycline 50mg/Vial Pd.Sol.Inf

Alphabetically

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Active Substance Strength Form
TeicoplaninUnder Development 200 mg & 400 mg/vial Pd.Sol.Inf
Tenoxicam 20mg/Vial Ps.Inj.Sol
Tenoxicam 20mg F.C.Tab
Terbinafine HCl 1% w/w (Tubx15g) Cr.Ext.Us
Ticlopidine HCl 250mg Caps
Tigecycline 50mg/Vial Pd.Sol.Inf
Active Substance Strength Form Market Availability
TeicoplaninUnder Development 200 mg & 400 mg/vial Pd.Sol.Inf Q1 2023
Tenoxicam 20mg/Vial Ps.Inj.Sol International
Tenoxicam 20mg F.C.Tab Selected Markets
Terbinafine HCl 1% w/w (Tubx15g) Cr.Ext.Us Selected Markets
Ticlopidine HCl 250mg Caps Selected Markets
Tigecycline 50mg/Vial Pd.Sol.Inf International